Amgen Technology Private Limited

Amgen Technology Private Limited - research & development in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U62099MH2007FTC168485 Incorporated 08 March 2007 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company research and development
Data last updated
Revenue · FY 2025
₹166.38 Cr
▲ 601.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
19 yrs
Est. 2007
Employees · EPFO
22
Latest available

About Amgen Technology Private Limited

Data last updated:

Amgen Technology Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Amgen Worldwide Holdings B V. The company specialises in research and development. Incorporated on 08 March 2007, the company has been in operation for over 19 years.

Registered with ROC Mumbai under CIN U62099MH2007FTC168485.

Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mansi Jayantilal Malkan and David Ewan Foulstone.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Park, Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹166.38 Cr, reflecting significant growth compared to the previous year.

The company has a workforce of approximately 22 employees as per the latest available data. It operates as a subsidiary of Amgen Worldwide Holdings B V.

The company is associated with 1 brand - Amgen.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amgen.com.

Company Details of Amgen Technology Private Limited
CIN U62099MH2007FTC168485
Registration Number 168485
Incorporation Date 08 March 2007
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Amgen Worldwide Holdings B V
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    10Th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon (E) Nesco I., T. Park, Mumbai, Maharashtra, India – 400063
  • Industry
    Research & Development, Research & Development
Company report
Amgen Technology Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Amgen Technology Private Limited report

Financials, compliance, directors, charges, ownership and filings for Amgen Technology Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Amgen Technology

Amgen Technology has one previous CIN (Corporate Identification Number): U24110MH2007FTC168485. The current CIN is U62099MH2007FTC168485, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U62099MH2007FTC168485Current
U24110MH2007FTC168485Previous

Associated Brands with Amgen Technology

Amgen Technology operates one associated brand: Amgen. Each brand links to its own profile.

BrandDescriptionWebsite
Developer of pharmaceutical products for treating multiple diseasesamgen.com

Competitors & Alternatives of Amgen Technology

Brands and companies operating in the same space as Amgen Technology Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

CompetitorDescriptionLocationFounded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide.Kenilworth, United Kingdom, United Kingdom1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.New York, United States, United States2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie.Chicago, United States, United States2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields.United States1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & othersFoster City, United States, United States1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized.Silver Spring, United States, United States1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases.Basel, Switzerland, Switzerland1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases.Hellerup, Denmark, Denmark2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed.Planegg, Germany, Germany1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disordersUnited States1989

Business Activity of Amgen Technology

The main business activity of Amgen Technology is professional, scientific and technical. In detail, this covers scientific research and development.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
MProfessional, Scientific and TechnicalM5Scientific research and developmentLocked
Premium access

Business activity turnover details for Amgen Technology Private Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Amgen Technology

Amgen Technology Private Limited is audited by S R B C & CO LLP for the financial year 2022.

NameStatusAppointment DateCessation Date
S R B C & CO LLPLockedLockedLocked
Premium access

Complete auditor history for Amgen Technology Private Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Amgen Technology Private Limited

Amgen Technology has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Mansi Jayantilal MalkanDirector15 Sep 20179 Years 0 MonthsCurrent
David Ewan FoulstoneDirector20 Mar 20242 Years 6 MonthsCurrent
Ng Lian Eric TeckDirector31 Aug 20179 Years 1 MonthsCurrent
Naveen GullapalliWhole-Time Director23 Apr 20251 Years 5 MonthsCurrent
Mihir Kumar OjhaWhole-Time Director09 May 20251 Years 4 MonthsCurrent

Financials of Amgen Technology Private Limited FY 2024 filings available

Amgen Technology Private Limited reported revenue of ₹166.38 Cr (up 601.00% YoY) for FY 2025.

Revenue · FY 2025
₹166.38 Cr ▲ 601.00%
Premium access

Ten-year financial statements for Amgen Technology Private Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Amgen Technology

Premium access

Shareholding and ownership data for Amgen Technology Private Limited

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Amgen Technology

Amgen Technology Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Amgen Technology

Amgen Technology Private Limited has a workforce of 22 employees as of Apr 01, 2024.

Employee count
22
Active EPFO establishments
1
Employee growth
-15.38%
Premium access

Employee and EPFO history for Amgen Technology Private Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Amgen Technology

Premium access

GST registrations and filing compliance for Amgen Technology Private Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Amgen Technology

Premium access

Credit ratings, litigation, and regulatory alerts for Amgen Technology Private Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Amgen Technology

Premium access

MSME payment history for Amgen Technology Private Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Amgen Technology

Premium access

Corporate group structure for Amgen Technology Private Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Amgen Technology

Premium access

MCA filings and documents for Amgen Technology Private Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Amgen Technology

Directors
09 May 2025
Mihir Kumar Ojha was appointed as a Whole-time director on 09 May 2025 & has been associated with this company since 1 year 4 months.
Directors
23 Apr 2025
Naveen Gullapalli was appointed as a Whole-time director on 23 Apr 2025 & has been associated with this company since 1 year 5 months.
Activity
30 Sep 2024
Amgen Technology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Activity
31 Mar 2024
Amgen Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Directors
20 Mar 2024
David Ewan Foulstone was appointed as a Director on 20 Mar 2024 & has been associated with this company since 2 years 6 months.
Directors
15 Sep 2017
Mansi Jayantilal Malkan was appointed as a Director on 15 Sep 2017 & has been associated with this company since 9 years 19 days.

Frequently Asked Questions about Amgen Technology Private Limited

Amgen Technology is an active foreign private limited company in the research and development sector based in Mumbai, Maharashtra, India. It was incorporated on 08 March 2007 (19+ years old) and is registered under CIN U62099MH2007FTC168485. The company has 22 employees.

Amgen Technology reported revenue of ₹166.38 Cr for FY 2025 (up 601.00% YoY).

The current directors of Amgen Technology are:

The primary industry of Amgen Technology is research and development. The company specifically operates in research and development. The company is currently active in this sector.

Amgen Technology can be reached at the registered office: 10Th Floor Nesco Tower 4 C Wing Western Express Highway Goregaon E Nesco I, T. Park, Mumbai, Maharashtra, India – 400063, or through the website amgen.com.

The authorised capital is ₹5 Lakh, and the paid-up capital is ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available